Si-Bone (SIBN) Invested Capital (2019 - 2022)

Si-Bone's (SIBN) quarterly Invested Capital came in at $1.5 million in Q3 2022, down 83.3% quarter-over-quarter from $8.7 million in Q1 2020.

Si-Bone (SIBN) Invested Capital (2019 - 2022) Analysis & Trends

Si-Bone's Invested Capital history runs 3 years deep, the most recent figure standing at $1.5 million for Q3 2022.

  • On a quarterly basis, Invested Capital changed N/A year-over-year to $1.5 million in Q3 2022; TTM through Jun 2023 was $1.5 million, a N/A change from a year earlier, with the FY2019 full-year figure at $4.4 million, changed N/A from the prior year.
  • Invested Capital fell to $1.5 million in Q3 2022 per SIBN's latest filing, from $8.7 million in the prior quarter.
  • Across five years, Invested Capital topped out at $8.7 million in Q1 2020 and bottomed at $1.5 million in Q3 2022.
  • The 3-year median for Invested Capital is $4.4 million (2019), against an average of $4.8 million.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 4.41 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 499.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 1.79 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 41.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 1.41 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 7.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 15.00 Mn
10 Si-Bone 724.02 Mn 579.33 Mn 41.94 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2022 1.46 Mn
Mar 31, 2020 8.73 Mn
Dec 31, 2019 4.36 Mn